advanced lung cancer
Conditions
Interventions
trial group:Qufeng Huoxue Prescription
control group1:oral vit B1
control group2:warm water soaking
Sponsors
Zhongshan Hospital, Fudan University
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: (1) Patients with advanced lung cancer were diagnosed by imaging and pathology; (2) The life expectancy of patients with advanced lung cancer is more than 6 months; (3) The PS (physical function state) score of patients with advanced lung cancer is 0-2 points; (4) They received chemotherapy containing taxanes for 4-6 cycles and maintenance treatment, with a weekly period of 3 weeks (21 days); (5) The condition is stable in the past 2 weeks (before participating in the study); (6) No restriction on sex, smoking or not; (7) Obtain written informed consent.
Exclusion criteria
Exclusion criteria: (1) The skin of the patient's hands and foot is broken and cannot be fumigated; (2) Patient is participating in another clinical trial; (3) Incapacity and researcher believes that patient is not suitable for the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| NCI-CTCAE 2-3 grade; | — |
Secondary
| Measure | Time frame |
|---|---|
| FACT/GOG-Ntx;Neuropathic pain scale, NPS;change chemotherapy dosage due to PIPN; | — |
Countries
China
Contacts
Public ContactYuanlin Song
Zhongshan Hospital, Fudan University
Outcome results
None listed